Azenta, Inc. (FRA:BA3)
Germany
· Delayed Price · Currency is EUR 29.60
-0.20 (-0.67%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| United States Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Africa Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific/ Other Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 593.82M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 593.82M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Sample Management Solutions Revenue | 325.00M |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Revenue | 269.00M |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -179.00K |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 593.82M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Revenue (Total) | 593.82M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 3
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Multiomics Revenue | 269.00M |
Log In |
Log In |
Log In | Upgrade
|
| Core Products Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Sample Repository Solutions Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Revenue | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 593.82M |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBIT
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Sample Management Solutions Adjusted Operating Income | 27.55M |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Adjusted Operating Income | -11.94M |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Systems Adjusted Operating Income | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -42.46M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -26.84M |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBIT 2
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Life Sciences Product Adjusted Operating Income | - |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Adjusted Operating Income | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -26.84M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2018 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2018 - 2020 |
| Organic Revenue Growth | 3.00% |
Log In |
Log In |
Log In | Upgrade
|